Inhibition by lithium of prostaglandin E1 and norepinephrine effects on cyclic adenosine monophosphate production in human platelets.
D000225:Adenine / Q000378:metabolism; D001792:Blood Platelets / Q000187:drug effects / Q000378:metabolism*; D000242:Cyclic AMP / Q000037:antagonists & inhibitors / Q000096:biosynthesis*; D003864:Depression, Chemical; D004298:Dopamine / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D006801:Humans; D066298:In Vitro Techniques; D008094:Lithium / Q000494:pharmacology*; D009638:Norepinephrine / Q000037:antagonists & inhibitors*; D011448:Prostaglandin Antagonists; D014316:Tritium
D011448:Prostaglandin Antagonists; D014316:Tritium; D008094:Lithium; D000242:Cyclic AMP; D000225:Adenine; D004298:Dopamine; D009638:Norepinephrine